Terminalcare Support Institute, Inc. (7362) AI Stock Analysis

• Market Cap: ¥1.29B
• Dividend Yield: N/A
• Average Volume (3M): 1.99K
• Price to Earnings (P/E): 13.8
• Beta (1Y): 0.41
• Revenue Growth: 7.06%
• EPS Growth: -27.80%
• Country: JP
• Employees: 451
• Sector: Healthcare
• Sector Strength: 40
• Industry: Medical - Care Facilities
• EPS (TTM): -19.05
• Shares Outstanding: 1,533,100
• 10 Day Avg. Volume: 840
• 30 Day Avg. Volume: 1,986
• PEG Ratio: -0.66
• Price to Book (P/B): 0.96
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥871.00
• Price Target Upside: 6.22% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 69 Neutral
• Price Target: ¥899.00 ▲(9.63%Upside)

The overall stock score is driven primarily by solid financial performance and fair valuation. While the company shows strong revenue growth and stable gross margins, challenges in profitability and rising debt levels are concerns. Technical indicators suggest a neutral trend with some potential for upward movement. The absence of a dividend yield and earnings call data slightly limits the stock's attractiveness.

Terminalcare Support Institute, Inc. Business Overview & Revenue Model

Company Description

Terminalcare Support Institute, Inc. (7362) is a leading provider of comprehensive support services aimed at enhancing the quality of life for individuals facing terminal illnesses. Operating primarily in the healthcare sector, the company specializes in palliative care, hospice services, and educational resources for both patients and caregivers. With a mission to deliver compassionate care and support, Terminalcare focuses on empowering families through innovative programs and personalized services tailored to meet the unique needs of those at the end of life.

How the Company Makes Money

Terminalcare Support Institute, Inc. generates revenue through multiple streams, primarily by offering paid services in palliative and hospice care. The company charges for its various care packages, which include in-home support, nursing services, and counseling for patients and their families. Additionally, Terminalcare partners with healthcare providers and insurance companies to receive reimbursements for services rendered, significantly contributing to its revenue. Educational programs and workshops for healthcare professionals and caregivers also serve as a secondary revenue stream, further solidifying its financial position in the healthcare landscape.

Terminalcare Support Institute, Inc. Financial Statement Overview

Summary

The company demonstrates solid revenue growth and profitability with a stable income statement. However, the balance sheet shows rising leverage, and negative free cash flow poses financial risks, highlighting cash flow management issues.

Income Statement

The company has demonstrated consistent revenue growth, with a 10.66% increase from 2023 to 2024. Gross Profit Margin for 2024 was 14.08%, and Net Profit Margin was 2.40% indicating stable profitability levels. However, the EBIT and EBITDA margins show some variability, with EBIT Margin at 2.80% and EBITDA Margin at 5.29%, reflecting potential operating cost pressures.

Balance Sheet

The Debt-to-Equity Ratio has increased to 2.14, which suggests rising leverage levels. However, the Return on Equity (ROE) stands at 8.63%, showing effective utilization of equity for generating profits. The Equity Ratio is 27.29%, indicating a moderate equity base relative to total assets.

Cash Flow

The Free Cash Flow has been negative, reflecting a challenging situation in managing capital expenditures with operational cash flows. The Operating Cash Flow to Net Income Ratio is 2.69, indicating strong cash generation relative to net income. However, the Free Cash Flow to Net Income Ratio is negative, pointing to cash flow management issues.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.71B	4.25B	4.10B	3.40B	2.93B
Gross Profit	664.67M	646.76M	685.84M	599.50M	464.84M
EBITDA	321.42M	300.83M	334.75M	284.93M	237.34M
Net Income	113.77M	126.67M	157.54M	138.03M	102.29M
Balance Sheet
Total Assets	4.80B	4.09B	3.03B	2.88B	2.06B
Cash, Cash Equivalents and Short-Term Investments	1.13B	1.38B	1.09B	874.72M	411.85M
Total Debt	2.81B	2.26B	1.34B	1.43B	1.44B
Total Liabilities	3.49B	2.90B	1.95B	1.95B	1.82B
Stockholders Equity	1.31B	1.19B	1.08B	927.37M	237.34M
Cash Flow
Free Cash Flow	-797.40M	-597.43M	303.05M	-57.27M	51.51M
Operating Cash Flow	304.51M	238.18M	812.73M	462.19M	124.89M
Investing Cash Flow	-1.10B	-836.33M	-510.68M	-523.54M	-74.58M
Financing Cash Flow	545.64M	892.46M	-90.11M	523.02M	-56.64M

Terminalcare Support Institute, Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 820.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7362, the sentiment is Neutral. The current price of 820 is below the 20-day moving average (MA) of 825.20, above the 50-day MA of 802.48, and below the 200-day MA of 855.52, indicating a neutral trend. The MACD of 4.52 indicates Positive momentum. The RSI at 51.26 is Neutral, neither overbought nor oversold. The STOCH value of 86.54 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7362.

Terminalcare Support Institute, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2425	79 Outperform	¥3.09B	8.26		2.46%	2.33%	-0.96%
9220	78 Outperform	¥2.69B	7.03		3.09%	5.85%	-22.29%
7129	75 Outperform	¥3.14B	9.86		2.67%	4.85%	4751.70%
7133	72 Outperform	¥10.98B	14.92		1.33%	20.50%	62.39%
7362	69 Neutral	¥1.29B	13.84		―	7.06%	-27.80%
Sector *	65 Neutral	¥354.29B	10.98	-2.99%	2.48%	11.72%	-10.32%
7061	63 Neutral	¥8.76B	15.84		1.44%	21.97%	-20.94%